Duncan Rudkin Chief Executive General Pharmaceutical Council 25 Canada Square Canary Wharf London E14 5LQ Sent by email 17.02.21 Dear Mr Rudkin, We call on you to provide reassurance to trans youth that their access to medication will...
Category: Pharmacy
Healthcare options for UK trans youth reach breaking point
Healthcare options for UK trans youth reach breaking point as pharmacies are targeted for providing lifesaving treatment UK Regulator Fails in its Duty of Care to Trans Youth GPhC accused of “forcing” resignation of trans inclusive superintendent pharmacist Action...
Fighting for Right of Trans Youth To Access Healthcare
Following news that pharmacists have once again been targeted for providing lifesaving treatment to trans youth, GenderGP would like to reassure our younger patients that we will continue to fight for your rights to access affirmative healthcare. The body that...
Pharmacies need regulator backing to support trans patients
Duncan Rudkin Chief Executive General Pharmaceutical Council 25 Canada Square Canary Wharf London E14 5LQ Sent by email 08.02.21 Dear Mr Rudkin, Pharmacies need the support of the GPhC in providing services to transgender patients. I am...
Open Letter to Matt Hancock
28 January 2021 The Rt. Hon Matt Hancock MP, Secretary of State for Health, House of Commons, London, SW1A 0AA Dr Helen Webberley Founder - GenderGP Office 7, 35-37 Ludgate Hill London EC4M 7JN www.GenderGP.com Dear Mr Hancock,...
Progesterone Benefits for Trans Women in Feminisation
Progesterone is widely used by MtF & AMAB transgender women. Interestingly enough, Progesterone's benefits for AMAB transgender women are vast. We ask, can it help with breast growth? Alternatively, does it help with mood, skin, joints, and general wellbeing?...
GIDS withdraw care
Dear *********, My understanding is that the UCLH clinic appointments will still go ahead but that medical treatment will be paused / not started, so unfortunately hormone blockers will not be prescribed to anyone who is not currently on them at present - this in...
Bell v Tavistock: Did GIDS failure to share key research impact the legal judgement
Polly Carmichael is the clinical director of the Tavistock GIDS service and Professor Gary Butler is the clinical director for the UCLH endocrine clinic that prescribes any medication after the Tavistock clinic has completed its assessments. Both Carmichael and Butler...
Bell v Tavistock: Questions on impact on GIDS processes remain
On 1 December, the Service Specifications for GIDS have updated following the Tavistock v Bell and Mrs A ruling. The key changes are as follows: New patients who have been assessed as being appropriate for puberty blockers must not be referred to the medical team at...
NHS Transgender Youth Healthcare. What Went Wrong?
The NHS Transgender Youth system is broken. For many years, the Gender Identity Development Service (GIDS) has received feedback that its protocols are causing harm. It has been accused of failing to facilitate joint decision-making and individual management plans,,...